Su-Jhen Hung
Sheng-Wen Huang- National Mosquito-Borne Diseases Control Research Center, National Health Research Institutes, Tainan, Taiwan
Mosquito-borne Zika virus (ZIKV) was considered an obscure virus causing only mild or self-limited symptoms until the explosive outbreaks in French Polynesia in 2013–2014 and in the Americas in 2015–2016, resulting in more than 700,000 cases of the disease, with occasional miscarriage and severe congenital birth defects, such as intrauterine growth restriction, fetal microcephaly, and other neurodevelopmental malformations. In this review, we summarized the evolution of ZIKV from a mundane virus to an epidemic virus. ZIKV has acquired a panel of amino acid substitutions during evolution when the virus spread from Africa, Asia, Pacific, through to the Americas. Robust occurrence of mutations in the evolution of ZIKV has increased its epidemic potential. Here we discussed the contributions of these evolutionary mutations to the enhancement of viral pathogenicity and host-mosquito transmission. We further explored the potential hypotheses for the increase in ZIKV activity in recent decades. Through this review, we also explored the hypotheses for the occurrence of the recent ZIKV epidemics and highlighted the potential roles of various factors including pathogen-, host-, vector-related, and environmental factors, which may have synergistically contributed to the ZIKV epidemics.
Introduction
Zika virus (ZIKV) belongs to the genus Flavivirus together with other important mosquito-borne human viruses, such as dengue virus (DENV), West Nile virus, Japanese encephalitis virus, and yellow fever virus. The flaviviruses have single positive-stranded 11-kb RNA genomes that the 5’ and 3’ untranslated regions flank a polyprotein coding region encoding three structural proteins [capsid, pre/membrane (prM), and envelope (E)] and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5). The main mosquito vector during epidemics belongs to the genus Aedes (Aedes aegypti and A. albopictus) (Diallo et al., 2014; Guo et al., 2016; Epelboin et al., 2017; Rossi et al., 2018). ZIKV has continuously adapted to mosquitoes and non-human primates in a sylvatic cycle, which then results in a virus reservoir. When ZIKV opportunistically enters the human transmission cycle from the sylvatic cycle, the virus may initiate epidemics in humans. In addition to the Aedes-human transmission cycle, non-vectored transmission between humans has been hypothesized because the ZIKV genome can be found in saliva (Musso et al., 2015), urine (Gourinat et al., 2015), and even tears (Miner et al., 2016).
Zika virus was first isolated from non-human primates in the Zika forest of Uganda in 1947 (Dick et al., 1952), and in humans in 1954 (Macnamara, 1954). Since then, it has been continuously isolated in Uganda and Nigeria (Simpson, 1964; Moore et al., 1975), and only sporadic cases with self-limited signs or mild symptoms were reported in Africa (Macnamara, 1954; Simpson, 1964; Moore et al., 1975; Fagbami, 1979) and South-east Asia (Olson and Ksiazek, 1981) until the first major outbreak, evidenced by serology and virology of patients with rash, fever, arthralgia, and conjunctivitis, occurred in Yap Island, Micronesia in 2007 (Duffy et al., 2009). Subsequently, ZIKV resumed low activity, and only a few countries including Cambodia (in 2008, 2009, and 2010), Nigeria (2011), Indonesia (2012), Russia (2012), and the Philippines (2012), reported ZIKV isolations from 2008 to 2012. Afterward, ZIKV caused another larger outbreak in French Polynesia in 2013–2014 (Cao-Lormeau et al., 2014), in which more than 30,000 individuals were observed for suspected infection. During this outbreak, ZIKV infections were first associated with patients with Guillain-Barré Syndrome (GBS), the neuropathic condition characterized by progressive weakness and diminished or absent myotatic reflexes (Walling and Dickson, 2013; Cao-Lormeau et al., 2016). Thereafter, ZIKV spread to several other Pacific islands, including Easter Island, Cook Island, Solomon Islands, New Caledonia, Vanuatu, Tonga, Fuji, Samoa, and American Samoa (Delatorre et al., 2018), and then to South American mainland. In May 2015, Brazil-originating ZIKV dissemination was reported (Zanluca et al., 2015), which then caused an explosive outbreak in September 2015. This outbreak casually linked ZIKV infection and birth defects or disabilities, such as severe microcephaly; the condition was termed congenital Zika syndrome (CZS). Simultaneously, ZIKV quickly spread from Brazil to the Caribbean and Central America and was eventually imported into the United States (Grubaugh et al., 2017). In 2016, at least 175,000 laboratory-confirmed ZIKV cases with more suspected cases from 48 countries and territories were reported in the Americas. Among these ZIKV-infected cases, World Health Organization reported 2,654 cases with CZS by February 2017, and 2,366 cases of these were in Brazil (World Health Organization, 2017). Although the prognosis of microcephaly needs to be more clearly examined, the patients with CZS usually have physical and learning disabilities. Therefore, CZS is a burden to families and societies. During the America epidemics, ZIKV strains continuously spread in Asia and caused an outbreak with 455 confirmed cases in Singapore in 2016 (Ho et al., 2017). Additionally, ZIKV locally disseminated and caused sporadic cases in the Philippines (Lim et al., 2017), Vietnam (Moi et al., 2017), and Thailand (Wongsurawat et al., 2018) in 2015–2016. Microcephaly was still noted among the clinical presentations of patients in Vietnam and Thailand, which indicated the general occurrence of CZS in America and Asia after 2015. Nonetheless, the reasons why ZIKV cases with CZS were not identified before 2015 is still unclear.
One of the plausible hypotheses is that ZIKV acquired some virulence mutations which contributed to the neurological infection in human fetal brains (Table 1). The nucleotide changes, along with amino acid substitutions, continuously accumulated over time and in different geographies, resulting in ZIKV evolution (Liu et al., 2019). The accumulated genetic diversity in the ZIKV population may increase the potential to cause severe diseases. To expand on this issue, we reviewed ZIKV evolution from the first isolation to recent emergent outbreaks and discussed the recent evidence on how the genetic changes affected ZIKV phenotypes, and on why ZIKV has become an emerging pathogen in recent outbreaks.
Table 1. Potential factors contributing to the recent emergence of Zika virus (ZIKV).
ZIKV Genetic Evolution: Genetic Changes From Obscureness to a Prominent Emerging Pathogen
The first ZIKV phylogenetic study was conducted after the 2007 Yap outbreak (Lanciotti et al., 2008). According to a phylogenetic study of the complete open reading frame sequence of the polyprotein, ZIKV has two lineages, the African (Nigeria, Senegal, and Uganda strains) and Asian (Malaysia 1966, Yap 2007, and Cambodia 2010) lineages (Haddow et al., 2012). According to the timescale of a phylogenetic tree estimation of ZIKV evolution (Delatorre et al., 2018), Asian ZIKV strains had two independent disseminations from Southeast Asia into the Pacific region–the first in Yap Island and the second in French Polynesia (Figure 1). With regards to the evidence that the Cambodia 2010 strain is the closest to the French Polynesia 2013 ZIKV outbreak strain, the former was sequentially introduced into the Pacific region and resulted in the 2013–2014 French Polynesia outbreak (Figure 1; Cao-Lormeau et al., 2014). Later, all of the Asian lineage strains isolated from American countries from 2014 including Brazil (Campos et al., 2015; Zanluca et al., 2015; Calvet et al., 2016), Colombia (Camacho et al., 2016), Puerto Rico (Lanciotti et al., 2016), and Guatemala (Lanciotti et al., 2016) showed phylogenetic and temporal closeness in the phylogenetic tree with >99% nucleotide identity with the French Polynesian strains (Lanciotti et al., 2016). Therefore, French Polynesian strains were suggested to simultaneously disseminate into the Easter Island, New Caledonia, the Cook Islands, and the Americas at approximately the same time, suggesting that these strains spread to the Americas and then caused a ZIKV epidemic globally in 2015–2016 (Figure 1). Simultaneously, the French Polynesian strain continued its dissemination in the Pacific countries including Samoa, Fiji, Tonga, and American Samoa in a stepping-stone process in 2015–2016 (Delatorre et al., 2018). Taken together, phylogenic evidence of ZIKV showed that the virus was first isolated in Africa and then was found in Asia. Afterward, ZIKV continuously evolved in Asia. ZIKV began to cause epidemics in the Pacific from 2000, including the 2007 Yap outbreak and the French Polynesia 2013–2014 outbreak. French Polynesia was suggested as the main origin for global ZIKV dissemination, which was sequentially introduced into the Americas where thousands of CZS cases were reported.
Figure 1. Global dissemination of Zika virus (ZIKV). ZIKV originated from Africa and was then introduced to Asia. Thereafter, ZIKV continuously evolved in Asia and began to cause outbreaks in the Pacific region from 2007. The 2013–2014 French Polynesia strain became the common ancestor worldwide and resulted in recent ZIKV outbreaks in the Americas. According to phylogenetic analysis, the African lineage viruses were circulated mainly in African countries, whereas those circulated in Asia, the Pacific regions, and the Americas were Asian lineage viruses. Countries or areas that have locally acquired ZIKV cases are colored with orange (African lineage circulation), purple (Asian lineage circulation), or gradient blue (the circulating lineage has not been confirmed).
Contribution of ZIKV Mutations to Fetal Microcephaly and Mosquito Transmission
To date, severe CZS cases have been found to be primarily caused by Asian ZIKV strains (D’Ortenzio et al., 2016), raising an important scientific question. That is, whether the accumulated mutations in ZIKV, particularly those acquired when the African strain evolved to the Asian lineages, contributes to the increase in CZS severity or transmissibility in mosquito vectors. Thus, several studies have investigated the phenotypic differences between African and Asian strains; however, the results obtained did not agree with the intuitive hypotheses. In vitro tissue culture evidence revealed that the African strains exhibit higher growth rates and induce higher rates of cellular apoptosis than the Asian strains in primate cell lines, such as Vero, human embryonic kidney (HEK293) cells, human neuronal progenitor cells (NPCs) as well as neuroblastoma, glioblastoma, and monocyte-derived dendritic cells (Simonin et al., 2016; Anfasa et al., 2017; Bowen et al., 2017; Shao et al., 2017; Sheridan et al., 2017; Smith et al., 2018). Similarly, an in vivo model conferred that the African strains have higher virulence than the Asian strains in mice (Dowall et al., 2017; Shao et al., 2017). Moreover, mosquitoes are more susceptible to the African strains than the Asian strains (Weger-Lucarelli et al., 2016; Azar et al., 2017; Roundy et al., 2017). Cumulatively these studies demonstrate that the Asian strains, responsible for the ZIKV outbreaks in the Pacific and the Americas, were less virulent with lower vector competence than the African strains.
Due to this evidence that was counterintuitive to the hypothesis for ZIKV emergence and the epidemic trends of ZIKV after 2007, more recent studies have focused on phenotypic comparison of the ancestral (Cambodia 2010) strain and different contemporary Asian strains isolated after 2010 (Liu et al., 2017; Yuan et al., 2017). One study utilized a mouse embryonic microcephaly model to compare the virulence of the ancestral and contemporary strains (Yuan et al., 2017). In vitro NPC results indicated that contemporary Asian strains showed a substantial increase in viral growth and cellular apoptosis in contrast with the ancestral strain. Contemporary strains also exhibited higher virulence in mouse brain tissue, and sequentially induced severe microcephaly phenotypes in embryonic brains in vivo (Liu et al., 2017). The authors compared the transmissibility of the ancestral Cambodia strain and contemporary Asian strain between the interferon receptor-deficient adult mice and A. aegypti mosquitoes. Although the ancestral and contemporary strains exhibited similar growth rates in AG6 mice, the contemporary China 2016 strain not only enhanced the ZIKV NS1 viremia, but also exhibited higher infectivity rates in the mosquitoes feeding on ZIKV-infected AG6 mice. In addition, the contemporary strain exhibited a fitness advantage in contrast with the ancestral strain, in both mice and mosquitoes (Liu et al., 2021). Taken together, the contemporary strain exhibits higher neurovirulence, causing microcephaly, as seen in the mouse model, enhancing the viral infectivity in mosquitoes, and possessing superior fitness than the ancestral strain in vivo.
Considering the numerous evolutionary mutations that have been identified in the contemporary strains, via phylogenetic analysis, various studies have applied reverse genetics systems to assess the contributions made by these mutations of ZIKV phenotype (Table 1; Liu et al., 2017; Yuan et al., 2017; Shan et al., 2020; Liu et al., 2021). Results have shown that the prM-S139N mutation accelerates viral replication in human NPCs, as well as viral virulence in the neonatal mouse model (Yuan et al., 2017). Furthermore, prM-S139N mutants have a more severe microcephalic phenotype with a thinner cortex, more robust brain cell apoptosis, and more NPC differentiation disruption, in contrast with the wild-type virus. Meanwhile, the E-V763M mutation was found to increase ZIKV replication, neurovirulence in neonatal mice, and maternal-to-fetal transmission (Shan et al., 2020). Additionally, the NS1-A982V mutation enhanced ZIKV infectivity in A. aegypti mosquitoes and elevated NS1 antigenemia without altering infective virus propagation in AG6 mice (Liu et al., 2017). Nonetheless, the NS1-A982V mutation enhanced ZIKV transmission not only from AG6 mice to mosquitoes, but also in a mosquito-mouse-mosquito transmission cycle. Additionally, the NS1-A982V mutation caused the NS1 protein to bind to TBK1, and subsequently reduce its phosphorylation level, which may inhibit interferon-beta production (Xia et al., 2018). In addition to single mutation, contemporary Asian strains possess C-T106A, prM-V123A, NS1-A982V, and NS5-M3392V, which serve to synergistically increase viral fitness in mice and mosquitoes (Liu et al., 2021). Cumulatively, these findings indicate that not only several single mutations, but also multiple mutations, have altered ZIKV phenotypic characteristics, including disease severity, transmission, and viral fitness.
Non-Mutation Based Potential Factors Responsible for the Recent ZIKV Emergence
Although additional ZIKV mutations, responsible for enhancing ZIKV neurovirulence, mosquito infectivity, and fitness, are likely to be characterized in the future, the general consensus is that other factors, aside from genetic mutations, have also contributed to the large outbreaks that occurred in 2015–2016 in the Americas (Table 1). Due to the nature of error-prone RNA virus replication, mutations can readily occur during ZIKV evolution and may represent a founder’s effect with a neutral fitness. Meanwhile, considering that the African strains are more virulent than the Asian strains, an alternative hypothesis is that all ZIKV strains have the rare capacity to cause severe neurological diseases through host-vector (urban), or host-host (sexual) transmission cycles (Rossi et al., 2018). Therefore, severe cases can only be detected by public health surveillance systems in a large outbreak; whereas in small outbreaks, such as the 2007 Yap State outbreak with approximately 5,000 human cases, the severe cases were not prevalent enough to be sufficiently recognized (Duffy et al., 2009). In contrast, with more than 30,000 cases of ZIKV diagnosed in the French Polynesia, and even greater numbers in the Americas, substantial rates of GBS or CZS cases were also detected during these devastating outbreaks. This alternative hypothesis may explain why infection by both African and Asian strains can result in fetus microcephaly and mosquito infectivity elevation. However, this hypothesis does not address one key question. That is, why was ZIKV activity substantially increased after the French Polynesia outbreak and robustly elevated during the American outbreak?
In addition to the pathogen, host factors including genetics and immunity represent major components in the epidemiologic triad of infectious diseases (Table 1). In a study comparing the NPCs from three pairs of dizygotic twins with different CZS in ZIKV infection, the cells exhibited diverse gene profiles for major regulators of the neurodevelopmental program, including the mTOR and WNT pathways. Moreover, the NPCs from affected individuals were more susceptible to ZIKV infection with accelerated viral replication and reduced cell growth (Caires-Junior et al., 2018). Hence, host genetics substantially affect the severity of ZIKV infection, even for dizygotic twins infected with the same strain in utero. Nonetheless, no specific loci associated with the CZS has been identified, suggesting that CZS may be a multifactorial disease with oligogenic and/or epigenetic mechanisms. Despite host genetics, pre-existing flavivirus immunity was suggested to modulate subsequential ZIKV disease outcome. Early in vitro and mouse studies reported that preexisting anti-DENV immunity associated with ZIKV pathogenesis via antibody-dependent enhancement (ADE) (Stettler et al., 2016; Bardina et al., 2017; Rathore et al., 2019); however, clinical and epidemiological evidence for ADE has not been provided yet. In contrast, human studies demonstrated that previous DENV immunity had no or cross-protection impact against ZIKV infection (Halai et al., 2017; Moreira-Soto et al., 2017; Castanha et al., 2019; Pedroso et al., 2019; Katzelnick et al., 2020; Michlmayr et al., 2020; Tonnerre et al., 2020; Petzold et al., 2021). In the Nicaraguan and Brazil pediatric cohorts, prior DENV infection and pre-existing anti-NS1 DENV antibodies were associated with reduced risk of ZIKV infection and disease (Gordon et al., 2019; Rodriguez-Barraquer et al., 2019). One epidemiological study observed that the areas with large DENV epidemics within 6 years had lower rates of CZS, which suggesting the protection role of recent DENV exposure (Carvalho et al., 2020). In murine models, DENV-immune Ifnar1–/– mice displayed that DENV-reactive CD8+ T cells mediate cross-protection against subsequent ZIKV challenge (Wen et al., 2017a, b; Regla-Nava et al., 2018). Heterotypic cross-protection may drive ZIKV evolution under the selection of flavivirus-reactive CD8+ T cell immunity in Asia where ZIKV has been circulating for decades in the face of heterotypic flavivirus immunity. In addition, heterotypic cross-protection provides potential explanation why only few CZS patients have been reported in Africa, another potential ZIKV-circulating continent with a high prevalence of heterotypic flaviviruses (Amarasinghe et al., 2011; Lourenco et al., 2018; Hill et al., 2019). Nonetheless, one aspect that cannot be discounted is the possibility that the number of ZIKV cases are underestimated in certain African nations due to potential misdiagnosis of ZIKV infection in areas endemic for other similar diseases, such as dengue fever.
The environment accounts for the third major component in the epidemiologic triad (Table 1). The 2015 El Niño resulted in record-breaking global temperatures, accompanied by severe drought throughout northern and eastern South America, during the second half of the year. These elevated temperatures did not only decrease the extrinsic incubation period, but also expanded the host range and increased the female mosquito biting rate (Morin et al., 2013; Paz and Semenza, 2016). In addition, the expansion of the Aedes spp. mosquito range correlates with an increase in water storage during regional periods of drought (Pontes et al., 2000). According to the correlation that was made regarding climate change and Aedes spp. expansion, a model was recently developed and applied to predict the time required for each A. aegypti life cycle based on the biophysical response to environment conditions (Iwamura et al., 2020). Results demonstrated that the world became approximately 1.5% more suitable per decade for the development of A. aegypti from 1950 to 2000 and will accelerate to 3.2–4.4% by 2050, emphasizing the recent gradual expansion of A. aegypti. These studies simultaneously indicate that global climate change, including temperature elevation, potentially increase the Aedes spp. development and expansion. Hence, all three major components, namely, pathogen, host, and environment, likely contribute to the observed increase in ZIKV prevalence and, as such, must each be taken into account when considering the recent ZIKV emergence.
Conclusion
We believe that multiple components have likely synergistically contributed to the debilitating ZIKV outbreaks observed in recent years. Although the number of ZIKV cases reported globally has declined since 2017, surveillance data shows that ZIKV continues to be detected in several areas and in travelers from endemic regions. In future, global surveillance, differential diagnosis, vector control, and virus sequencing are required for prompt monitoring of the transmission dynamics and providing early warnings of possible ZIKV outbreaks in future. Moreover, ZIKV vaccine development is urgently needed to control the next wave of a potential outbreak; however, preexisting flavivirus antibodies in people with prior flavivirus infection or vaccination call for great caution in the design and implementation of vaccines.
Author Contributions
S-WH and S-JH: conceptualization, data curation, writing – original draft, and writing – review and editing. S-WH: project administration, resources, supervision, and visualization. Both authors contributed to the article and approved the submitted version.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Funding
S-WH received funding from the National Health Research Institutes (Grant Number: MR-110-GP-04; http://www.nhri.org.tw/). The funders had no role in data collection, and analysis, decision to publish, or preparation of the manuscript.
Acknowledgments
We would like to thank the Ministry of Health and Welfare in Taiwan and National Health Research Institutes for the research support.
References
Amarasinghe, A., Kuritsky, J. N., Letson, G. W., and Margolis, H. S. (2011). Dengue virus infection in Africa. Emerg. Infect. Dis. 17:1349. doi: 10.3201/eid1708.101515
Anfasa, F., Siegers, J. Y., van der Kroeg, M., Mumtaz, N., Raj, V. S., de Vrij, F. M., et al. (2017). Phenotypic differences between Asian and African lineage Zika viruses in human neural progenitor cells. mSphere 2:e00292. doi: 10.1128/mSphere.00292-17
Azar, S. R., Roundy, C. M., Rossi, S. L., Huang, J. H., Leal, G., Yun, R., et al. (2017). Differential vector competency of Aedes albopictus populations from the Americas for Zika virus. Am. J. Trop. Med. Hyg. 97, 330–339. doi: 10.4269/ajtmh.16-0969
Bardina, S. V., Bunduc, P., Tripathi, S., Duehr, J., Frere, J. J., Brown, J. A., et al. (2017). Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science 356, 175–180. doi: 10.1126/science.aal4365
Bowen, J. R., Quicke, K. M., Maddur, M. S., O’Neal, J. T., McDonald, C. E., Fedorova, N. B., et al. (2017). Zika virus antagonizes type I interferon responses during infection of human dendritic cells. PLoS Pathog. 13:e1006164. doi: 10.1371/journal.ppat.1006164
Caires-Junior, L. C., Goulart, E., Melo, U. S., Araujo, B. H. S., Alvizi, L., Soares-Schanoski, A., et al. (2018). Discordant congenital Zika syndrome twins show differential in vitro viral susceptibility of neural progenitor cells. Nat. Commun. 9:475. doi: 10.1038/s41467-017-02790-9
Calvet, G., Aguiar, R. S., Melo, A. S., Sampaio, S. A., De Filippis, I., Fabri, A., et al. (2016). Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect. Dis. 16, 653–660. doi: 10.1016/S1473-3099(16)00095-5
Camacho, E., Paternina-Gomez, M., Blanco, P. J., Osorio, J. E., and Aliota, M. T. (2016). Detection of autochthonous Zika virus transmission in Sincelejo, Colombia. Emerg. Infect. Dis. 22:927. doi: 10.3201/eid2205.160023
Campos, G. S., Bandeira, A. C., and Sardi, S. I. (2015). Zika virus outbreak, Bahia, Brazil. Emerg. Infect. Dis. 21:1885. doi: 10.3201/eid2110.150847
Cao-Lormeau, V. M., Blake, A., Mons, S., Lastère, S., Roche, C., Vanhomwegen, J., et al. (2016). Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387, 1531–1539. doi: 10.1016/S0140-6736(16)00562-6
Cao-Lormeau, V. M., Roche, C., Teissier, A., Robin, E., Berry, A. L., Mallet, H. P., et al. (2014). Zika virus, French polynesia, South pacific, 2013. Emerg. Infect. Dis. 20:1085. doi: 10.3201/eid2006.140138
Carvalho, M. S., Freitas, L. P., Cruz, O. G., Brasil, P., and Bastos, L. S. (2020). Association of past dengue fever epidemics with the risk of Zika microcephaly at the population level in Brazil. Sci. Rep. 10:1752. doi: 10.1038/s41598-020-58407-7
Castanha, P. M. S., Souza, W. V., Braga, C., Araujo, T. V. B., Ximenes, R. A. A., Albuquerque, M., et al. (2019). Perinatal analyses of Zika- and dengue virus-specific neutralizing antibodies: a microcephaly case-control study in an area of high dengue endemicity in Brazil. PLoS Negl. Trop. Dis. 13:e0007246. doi: 10.1371/journal.pntd.0007246
Delatorre, E., Fernández, J., and Bello, G. (2018). Investigating the role of easter island in migration of Zika virus from South Pacific to Americas. Emerg. Infect. Dis. 24:2119. doi: 10.3201/eid2411.180586
Diallo, D., Sall, A. A., Diagnes, C. T., Faye, O., Faye, O., Ba, Y., et al. (2014). Zika virus emergence in mosquitoes in southeastern Senegal, 2011. PLoS One 9:e109442. doi: 10.1371/journal.pone.0109442
Dick, G. W., Kitchen, S. F., and Haddow, A. J. (1952). Zika virus (I). Isolations and serological specificity. Trans. R. Soc. Trop. Med. Hyg. 46, 509–520. doi: 10.1016/0035-9203(52)90042-4
D’Ortenzio, E., Matheron, S., de Lamballerie, X., Hubert, B., Piorkowski, G., Maquart, M., et al. (2016). Evidence of sexual transmission of Zika virus. N. Engl. J. Med. 374, 2195–2198. doi: 10.1056/NEJMc1604449
Dowall, S. D., Graham, V. A., Rayner, E., Hunter, L., Atkinson, B., Pearson, G., et al. (2017). Lineage-dependent differences in the disease progression of Zika virus infection in type-I interferon receptor knockout (A129) mice. PLoS Negl. Trop. Dis. 11:e0005704. doi: 10.1371/journal.pntd.0005704
Duffy, M. R., Chen, T. H., Hancock, W. T., Powers, A. M., Kool, J. L., Lanciotti, R. S., et al. (2009). Zika virus outbreak on Yap Island, federated states of Micronesia. N. Engl. J. Med. 360, 2536–2543. doi: 10.1056/NEJMoa0805715
Epelboin, Y., Talaga, S., Epelboin, L., and Dusfour, I. (2017). Zika virus: an updated review of competent or naturally infected mosquitoes. PLoS Negl. Trop. Dis. 11:e0005933. doi: 10.1371/journal.pntd.0005933
Fagbami, A. H. (1979). Zika virus infections in Nigeria: virological and seroepidemiological investigations in Oyo State. Epidemiol. Infect. 83, 213–219. doi: 10.1017/s0022172400025997
Gordon, A., Gresh, L., Ojeda, S., Katzelnick, L. C., Sanchez, N., Mercado, J. C., et al. (2019). Prior dengue virus infection and risk of Zika: a pediatric cohort in Nicaragua. PLoS Med 16:e1002726. doi: 10.1371/journal.pmed.1002726
Gourinat, A. C., O’Connor, O., Calvez, E., Goarant, C., and Dupont-Rouzeyrol, M. (2015). Detection of Zika virus in urine. Emerg. Infect. Dis. 21, 84–86. doi: 10.3201/eid2101.140894
Grubaugh, N. D., Ladner, J. T., Kraemer, M. U., Dudas, G., Tan, A. L., Gangavarapu, K., et al. (2017). Genomic epidemiology reveals multiple introductions of Zika virus into the United States. Nature 546, 401–405. doi: 10.1038/nature22400
Guo, X. X., Li, C. X., Deng, Y. Q., Xing, D., Liu, Q. M., Wu, Q., et al. (2016). Culex pipiens quinquefasciatus: a potential vector to transmit Zika virus. Emerg. Microbes Infect. 5:e102. doi: 10.1038/emi.2016.102
Haddow, A. D., Schuh, A. J., Yasuda, C. Y., Kasper, M. R., Heang, V., Huy, R., et al. (2012). Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage. PLoS Negl. Trop. Dis. 6:e1477. doi: 10.1371/journal.pntd.0001477
Halai, U. A., Nielsen-Saines, K., Moreira, M. L., de Sequeira, P. C., Junior, J. P. P., de Araujo Zin, A., et al. (2017). Maternal zika virus disease severity, virus load, prior dengue antibodies, and their relationship to birth outcomes. Clin. Infect. Dis. 65, 877–883. doi: 10.1093/cid/cix472
Hill, S. C., Vasconcelos, J., Neto, Z., Jandondo, D., Zé-Zé, L., Aguiar, R. S., et al. (2019). Emergence of the Asian lineage of Zika virus in Angola: an outbreak investigation. Lancet Infect. Dis. 19, 1138–1147. doi: 10.1016/S1473-3099(19)30293-2
Ho, Z. J. M., Hapuarachchi, H. C., Barkham, T., Chow, A., Ng, L. C., Lee, J. M. V., et al. (2017). Outbreak of Zika virus infection in Singapore: an epidemiological, entomological, virological, and clinical analysis. Lancet Infect. Dis. 17, 813–821. doi: 10.1016/S1473-3099(17)30249-9
Iwamura, T., Guzman-Holst, A., and Murray, K. A. (2020). Accelerating invasion potential of disease vector Aedes aegypti under climate change. Nat. Commun. 11:2130. doi: 10.1038/s41467-020-16010-4
Katzelnick, L. C., Bos, S., and Harris, E. (2020). Protective and enhancing interactions among dengue viruses 1-4 and Zika virus. Curr. Opin. Virol. 43, 59–70. doi: 10.1016/j.coviro.2020.08.006
Lanciotti, R. S., Kosoy, O. L., Laven, J. J., Velez, J. O., Lambert, A. J., Johnson, A. J., et al. (2008). Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg. Infect. Dis. 14:1232. doi: 10.3201/eid1408.080287
Lanciotti, R. S., Lambert, A. J., Holodniy, M., Saavedra, S., and Signor, L. D. C. C. (2016). Phylogeny of Zika virus in western hemisphere, 2015. Emerg. Infect. Dis. 22:933. doi: 10.3201/eid2205.160065
Lim, S. K., Lim, J. K., and Yoon, I. K. (2017). An update on Zika virus in Asia. Infect. Chemother. 49, 91–100. doi: 10.3947/ic.2017.49.2.91
Liu, J., Liu, Y., Shan, C., Nunes, B. T. D., Yun, R., Haller, S. L., et al. (2021). Role of mutational reversions and fitness restoration in Zika virus spread to the Americas. Nat. Commun. 12:595. doi: 10.1038/s41467-020-20747-3
Liu, Y., Liu, J., Du, S., Shan, C., Nie, K., Zhang, R., et al. (2017). Evolutionary enhancement of Zika virus infectivity in Aedes aegypti mosquitoes. Nature 545, 482–486. doi: 10.1038/nature22365
Liu, Z. Y., Shi, W. F., and Qin, C. F. (2019). The evolution of Zika virus from Asia to the Americas. Nat. Rev. Microbiol. 17, 131–139. doi: 10.1038/s41579-018-0134-9
Lourenco, J., de Lourdes Monteiro, M., Valdez, T., Rodrigues, J. M., Pybus, O., and Faria, N. R. (2018). Epidemiology of the Zika virus outbreak in the Cabo Verde Islands, West Africa. PLoS Curr. 10:ecurrents.outbreaks.19433b1e4d007451c691f138e1e67e8c. doi: 10.1371/currents.outbreaks.19433b1e4d007451c691f138e1e67e8c
Macnamara, F. N. (1954). Zika virus: a report on three cases of human infection during an epidemic of jaundice in Nigeria. Trans. R. Soc. Trop. Med. Hyg. 48, 139–145. doi: 10.1016/0035-9203(54)90006-1
Michlmayr, D., Kim, E. Y., Rahman, A. H., Raghunathan, R., Kim-Schulze, S., Che, Y., et al. (2020). Comprehensive immunoprofiling of pediatric Zika reveals key role for monocytes in the acute phase and no effect of prior dengue virus infection. Cell Rep. 31:107569. doi: 10.1016/j.celrep.2020.107569
Miner, J. J., Sene, A., Richner, J. M., Smit, A. M., Santeford, A., Ban, N., et al. (2016). Zika virus infection in mice causes panuveitis with shedding of virus in tears. Cell Rep. 16, 3208–3218. doi: 10.1016/j.celrep.2016.08.079
Moi, M. L., Nguyen, T. T. T., Nguyen, C. T., Vu, T. B. H., Tun, M. M. N., Pham, T. D., et al. (2017). Zika virus infection and microcephaly in Vietnam. Lancet Infect. Dis. 17, 805–806. doi: 10.1016/S1473-3099(17)30412-7
Moore, D. Á, Causey, O. R., Carey, D. E., Reddy, S., Cooke, A. R., Akinkugbe, F. M., et al. (1975). Arthropod-borne viral infections of man in Nigeria, 1964–1970. Ann. Trop. Med. Parasitol. 69, 49–64. doi: 10.1080/00034983.1975.11686983
Moreira-Soto, A., Sarno, M., Pedroso, C., Netto, E. M., Rockstroh, A., Luz, E., et al. (2017). Evidence for congenital zika virus infection from neutralizing antibody titers in maternal sera, northeastern Brazil. J. Infect. Dis. 216, 1501–1504. doi: 10.1093/infdis/jix539
Morin, C. W., Comrie, A. C., and Ernst, K. (2013). Climate and dengue transmission: evidence and implications. Environ. Health Perspect. 121, 1264–1272. doi: 10.1289/ehp.1306556
Musso, D., Roche, C., Nhan, T. X., Robin, E., Teissier, A., and Cao-Lormeau, V. M. (2015). Detection of Zika virus in saliva. J. Clin. Virol. 68, 53–55. doi: 10.1016/j.jcv.2015.04.021
Olson, J. G., and Ksiazek, T. G. (1981). Zika virus, a cause of fever in Central Java, Indonesia. Trans. R. Soc. Trop. Med. Hyg. 75, 389–393. doi: 10.1016/0035-9203(81)90100-0
Paz, S., and Semenza, J. C. (2016). El Niño and climate change–contributing factors in the dispersal of Zika virus in the Americas? Lancet 387:745. doi: 10.1016/S0140-6736(16)00256-7
Pedroso, C., Fischer, C., Feldmann, M., Sarno, M., Luz, E., Moreira-Soto, A., et al. (2019). Cross-protection of dengue virus infection against congenital zika syndrome, northeastern brazil. Emerg. Infect. Dis. 25, 1485–1493. doi: 10.3201/eid2508.190113
Petzold, S., Agbaria, N., Deckert, A., Dambach, P., Winkler, V., Drexler, J. F., et al. (2021). Congenital abnormalities associated with Zika virus infection-Dengue as potential co-factor? A systematic review. PLoS. Negl. Trop. Dis. 15:e0008984. doi: 10.1371/journal.pntd.0008984
Pontes, R. J., Freeman, J., Oliveira-Lima, L. W., Hodgson, J. C., and Spielman, A. (2000). Vector densities that potentiate dengue outbreaks in a Brazilian city. Am. J. Trop. Med. Hyg. 62, 378–383. doi: 10.4269/ajtmh.2000.62.378
Rathore, A. P. S., Saron, W. A. A., Lim, T., Jahan, N., and St. John, A. L. (2019). Maternal immunity and antibodies to dengue virus promote infection and Zika virus-induced microcephaly in fetuses. Sci. Adv 5:eaav3208. doi: 10.1126/sciadv.aav3208
Regla-Nava, J. A., Elong Ngono, A., Viramontes, K. M., Huynh, A. T., Wang, Y. T., Nguyen, A. T., et al. (2018). Cross-reactive Dengue virus-specific CD8+ T cells protect against Zika virus during pregnancy. Nat. Commun. 9:3042. doi: 10.1038/s41467-018-05458-0
Rodriguez-Barraquer, I., Costa, F., Nascimento, E. J. M., Castanha, P. M. S., Sacramento, G. A., Cruz, J., et al. (2019). Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region. Science 363, 607–610. doi: 10.1126/science.aav6618
Rossi, S. L., Ebel, G. D., Shan, C., Shi, P. Y., and Vasilakis, N. (2018). Did Zika virus mutate to cause severe outbreaks? Trends. Microbiol. 26, 877–885. doi: 10.1016/j.tim.2018.05.007
Roundy, C. M., Azar, S. R., Brault, A. C., Ebel, G. D., Failloux, A. B., Fernandez-Salas, I., et al. (2017). Lack of evidence for Zika virus transmission by Culex mosquitoes. Emerg. Microbes Infect. 6:e90. doi: 10.1038/emi.2017.85
Shan, C., Xia, H., Haller, S. L., Azar, S. R., Liu, Y., Liu, J., et al. (2020). A Zika virus envelope mutation preceding the 2015 epidemic enhances virulence and fitness for transmission. Proc. Natl. Acad. Sci. U.S.A. 117, 20190–20197. doi: 10.1073/pnas.2005722117
Shao, Q., Herrlinger, S., Zhu, Y. N., Yang, M., Goodfellow, F., Stice, S. L., et al. (2017). The African Zika virus MR-766 is more virulent and causes more severe brain damage than current Asian lineage and dengue virus. Development 144, 4114–4124. doi: 10.1242/dev.156752
Sheridan, M. A., Yunusov, D., Balaraman, V., Alexenko, A. P., Yabe, S., Verjovski-Almeida, S., et al. (2017). Vulnerability of primitive human placental trophoblast to Zika virus. Proc. Natl. Acad. Sci. U S A. 114, E1587–E1596. doi: 10.1073/pnas.1616097114
Simonin, Y., Loustalot, F., Desmetz, C., Foulongne, V., Constant, O., Fournier-Wirth, C., et al. (2016). Zika virus strains potentially display different infectious profiles in human neural cells. EBioMedicine 12, 161–169. doi: 10.1016/j.ebiom.2016.09.020
Simpson, D. I. H. (1964). Zika virus infection in man. Trans. R. Soc. Trop. Med. Hyg. 58, 335–338. doi: 10.1016/0035-9203(64)90201-9
Smith, D. R., Sprague, T. R., Hollidge, B. S., Valdez, S. M., Padilla, S. L., Bellanca, S. A., et al. (2018). African and Asian Zika virus isolates display phenotypic differences both in vitro and in vivo. Am. J. Trop. Med. Hyg. 98, 432–444. doi: 10.4269/ajtmh.17-0685
Stettler, K., Beltramello, M., Espinosa, D. A., Graham, V., Cassotta, A., Bianchi, S., et al. (2016). Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353, 823–826. doi: 10.1126/science.aaf8505
Tonnerre, P., Melgaço, J. G., Torres-Cornejo, A., Pinto, M. A., Yue, C., Blümel, J., et al. (2020). Evolution of the innate and adaptive immune response in women with acute Zika virus infection. Nat. Microbiol. 5, 76–83. doi: 10.1038/s41564-019-0618-z
Weger-Lucarelli, J., Ruckert, C., Chotiwan, N., Nguyen, C., Garcia Luna, S. M., Fauver, J. R., et al. (2016). Vector competence of American mosquitoes for three strains of Zika virus. PLoS Negl. Trop. Dis. 10:e0005101. doi: 10.1371/journal.pntd.0005101
Wen, J., Ngono, A. E., Regla-Nava, J. A., Kim, K., Gorman, M. J., Diamond, M. S., et al. (2017a). Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent Zika virus challenge. Nat. Commun. 8:1459. doi: 10.1038/s41467-017-01669-z
Wen, J., Tang, W. W., Sheets, N., Ellison, J., Sette, A., Kim, K., et al. (2017b). Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8+ T cells. Nat. Microbiol. 2:17036. doi: 10.1038/nmicrobiol.2017.36
Wongsurawat, T., Athipanyasilp, N., Jenjaroenpun, P., Jun, S. R., Kaewnapan, B., Wassenaar, T. M., et al. (2018). Case of microcephaly after congenital infection with Asian lineage Zika virus, Thailand. Emerg. Infect. Dis. 24:1758. doi: 10.3201/eid2409.180416
World Health Organization (2017). Zika Situation Report. Availble online at: https://www.who.int/emergencies/zika-virus/situation-report/en/ (accessed March 10, 2017).
Xia, H., Luo, H., Shan, C., Muruato, A. E., Nunes, B. T., Medeiros, D. B., et al. (2018). An evolutionary NS1 mutation enhances Zika virus evasion of host interferon induction. Nat. Commun. 9:414. doi: 10.1038/s41467-017-02816-2
Yuan, L., Huang, X. Y., Liu, Z. Y., Zhang, F., Zhu, X. L., Yu, J. Y., et al. (2017). A single mutation in the prM protein of Zika virus contributes to fetal microcephaly. Science 358, 933–936. doi: 10.1126/science.aam7120
Keywords: Zika virus, evolution, virulence, mutation, emergence
Citation: Hung S-J and Huang S-W (2021) Contributions of Genetic Evolution to Zika Virus Emergence. Front. Microbiol. 12:655065. doi: 10.3389/fmicb.2021.655065
Received: 18 January 2021; Accepted: 12 April 2021;
Published: 06 May 2021.
Edited by:
Justin Jang Hann Chu, National University of Singapore, SingaporeReviewed by:
Hongjie Xia, University of Texas Medical Branch at Galveston, United StatesSujan Shresta, La Jolla Institute for Immunology, United States
Copyright © 2021 Hung and Huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Sheng-Wen Huang, am9laHVhbmdAbmhyaS5lZHUudHc=